Dr. Socinski on Challenges Facing Immunotherapy Combinations – OncLive
OncLive |
Dr. Socinski on Challenges Facing Immunotherapy Combinations
OncLive Immunotherapy is an exciting treatment, but it can be improved upon in several ways, explains Socinski. There is supporting evidence stating that selecting patients who strongly stain for PD-L1 have better outcomes when treated with immunotherapies. |
